Sermorelin was discontinued for industrial business explanations, not as a result of its protection profiles. It couldn't compete successfully with rhGH being a growth hormone therapy from the pediatric sector, which led the company to stop its production.Not a controlled substance, not on any FDA limited record — Probably the most legally straig